Chemically Programmable and Switchable CAR‐T Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemically Programmable and Switchable CAR‐T Therapy

Published:2020-05-18 Issue:29 Volume:59 Page:12178-12185
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Qi Junpeng¹,Tsuji Kohei²³,Hymel David²,Burke Terrence R.²,Hudecek Michael⁴,Rader Christoph¹^ORCID,Peng Haiyong¹

Affiliation:

1. Department of Immunology and Microbiology The Scripps Research Institute 130 Scripps Way Jupiter FL 33458 USA

2. Chemical Biology Laboratory Center for Cancer Research National Cancer Institute National Institutes of Health Building 376 Boyles Street Frederick MD 21702 USA

3. Department of Medicinal Chemistry Institute of Biomaterials and Bioengineering Tokyo Medical and Dental University 2-3-10 Kandasurugadai, Chiyoda-ku Tokyo 101-0062 Japan

4. Medizinische Klinik und Poliklinik II Universitätsklinikum Würzburg Oberdürrbacherstrasse 6 97080 Würzburg Germany

Funder

National Institutes of Health

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.202005432

Reference53 articles.

1.

2. CAR T cell immunotherapy for human cancer

3. Therapeutic T cell engineering

4. FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia

5. Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electrophilic proximity-inducing synthetic adapters enhance universal T cell function by covalently enforcing immune receptor signaling;Molecular Therapy: Oncology;2024-09

2. Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy;Journal of Translational Medicine;2024-08-05

3. In vivo manufacture and manipulation of CAR-T cells for better druggability;Cancer and Metastasis Reviews;2024-04-09

4. CAR‐T‐cell products in solid tumors: Progress, challenges, and strategies;Interdisciplinary Medicine;2024-04

5. Aptamer-Based Nongenetic Reprogramming of CARs Enables Flexible Modulation of T Cell-Mediated Tumor Immunotherapy;ACS Central Science;2024-03-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3